ReviewMolecular medicine reports2026
Circular RNAs in intervertebral disc degeneration: Current insights into mechanisms and therapeutic potentials (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low back pain (LBP) is a leading cause of productivity loss worldwide and a major contributor to disability, imposing an economic burden on society. Intervertebral disc degeneration (IVDD) as a principal pathological driver of LBP remains a formidable therapeutic challenge, given that existing conservative and surgical interventions frequently fall short of achieving long‑term efficacy or halting disease progression. Advancements in molecular biology have revealed that circular RNAs (circRNAs) play a pivotal role in the intricate gene regulatory networks governing IVDD. The most extensively studied function of circRNAs is their ability to act as microRNA sponges. In addition, they participate in protein interactions, regulate gene transcription and serve as templates for protein translation. The present review provided a comprehensive overview of the current understanding of circRNA characteristics and functions, elucidated their involvement in IVDD pathogenesis and examined the therapeutic potential of emerging biomaterials for IVDD treatment. By consolidating existing research, the aim of this review was to offer theoretical foundations for innovative therapeutic strategies targeting IVDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.